Regentis Biomaterials Ltd. (RGNT)
NYSEAMERICAN: RGNT · Real-Time Price · USD
3.360
0.00 (0.00%)
Mar 9, 2026, 1:01 PM EDT - Market open
Regentis Biomaterials Market Cap
Regentis Biomaterials has a market cap or net worth of $17.40 million as of March 9, 2026.
Market Cap
17.40M
Enterprise Value
11.22M
1-Year Change
n/a
Ranking
Category
Stock Price
$3.36
Market Cap Chart
Since the IPO on December 4, 2025, Regentis Biomaterials's market cap has decreased from $39.44M to $17.40M, a decrease of -55.87%. That is a compound annual growth rate of -96.10%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 6, 2026 | 17.40M | -50.15% |
| Dec 31, 2025 | 34.91M | -11.48% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 884.72B |
| Johnson & Johnson | 579.34B |
| AbbVie | 406.87B |
| Novartis AG | 302.19B |
| Pasithea Therapeutics | 18.39M |
| IN8bio | 16.80M |
| Apimeds Pharmaceuticals US | 16.73M |
| P3 Health Partners | 16.64M |